The Pharmacy and Poisons Board (PPB) has suspended the licenses of four pharmaceutical practitioners over professional misconduct.
In a statement on Monday, September 9, PPB CEO Fred Siyoi said the decision was taken by the board’s Enquiries and Disciplinary Committee (EDC).
In a decision led by the Committee's Chairperson, Dr. Richard Muthoka, two pharmaceutical technologists had their licenses suspended for two years.
The two practitioners were found guilty of allowing unlicensed individuals to access their professional credentials and manage their licensed premises thereby endangering public health.
"After a thorough review of the facts and your written confessions, the Board concludes that your actions represent a serious breach of trust and integrity, essential qualities for anyone in the pharmaceutical field, read part of the Committee's decision.
Read More
Another pharmaceutical technologist was suspended for three months after failing to ensure the proper closure of a former site.
According to PPB, this allowed an unqualified person to continue overseeing operations, posing a risk to public safety.
The Board also suspended the license of a pharmaceutical technologist for three years after he was found to have impersonated a student during the Board's May 2024 examination series.
“The Board reaffirms its commitment to regulating the pharmacy profession to protect public health,” the statement added.
